CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Jalucomplexdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04103918
NCT04103918N/ACompleted
CompareCT.gov

Open, Non-Comparative Study To Evaluate The Performance And Safety Of The Medical Device Jalucomplex® (Hyaluronic Acid-Dermal Filler) In the Treatment Of Facial And Neck Wrinkles To Obtain Facial Rejuvanation

I.R.A. Istituto Ricerche Applicate S.p.A.·interventional·Posted Sep 26, 2019·Updated Apr 12, 2021

In Brief

A clinical study evaluating Jalucomplex for Wrinkle. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The Research Question of the present study is the following: in a population of men and women affected by facial and neck wrinkles, will linear hyaluronic acid (Jalucomplex®) significantly decrease the appearance of facial and neck wrinkles, results observed after 12 weeks?

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsWrinkle
CountriesRomania
CollaboratorsOpera CRO, a TIGERMED Group Company

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedSep 26, 2019
Enrollment StartAug 24, 2020
Primary CompletionJan 20, 2021
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 6.8 years ago

Interventions

Jalucomplexdevice

Jalucomplex is an injectable intradermal gel containing sodium salts derived from hyaluronic acid.